Terminated PHASE2/PHASE3 INTERVENTIONAL 9-arm NCT00675714

Assessment of the Treatment of Severely Burned With Anabolic Agents on Clinical Outcomes, Recovery and Rehabilitation

Assessment of the Treatment of the Severely Burned With Anabolic Agents on Clinical Outcomes, Recovery and Rehabilitation

Sponsor: National Institute of General Medical Sciences (NIGMS)

Conditions Burns

Interventions Collection of blood and tissues Exercise--Hospital supervised intensive exercise program Home exercise program Humatrope Humatrope and propranolol combined Ketoconazole Oxandrolone Oxandrolone and propranolol combined Placebo Propranolol Radiology testing: Dual-energy X-ray absorptiometry (DEXA), ultrasound, MRI Stable Isotope Infusion Study

Updated 11 times since 2017 Last updated: Nov 26, 2019 Started: Jan 31, 2004 Primary completion: Sep 30, 2018 Completion: Jul 15, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

At the request of the study site, this study has been closed and access to study-related data is unavailable. We are unable to submit the results-data.

Other terminated trials from National Institute of General Medical Sciences (NIGMS)

See all terminations from National Institute of General Medical Sciences (NIGMS)

Other Burns trials with similar outcome

Browse all Burns trials

This PHASE2/PHASE3 trial investigates Burns and is currently terminated or withdrawn. National Institute of General Medical Sciences (NIGMS) leads this study, which shows 11 recorded versions since 2004 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

11 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Dec 2021 — Jul 2024 [monthly]

Terminated PHASE2_PHASE3
Jan 2021 — Dec 2021 [monthly]

Terminated PHASE2_PHASE3
Nov 2020 — Jan 2021 [monthly]

Terminated PHASE2_PHASE3

▶ Show 6 earlier versions

Dec 2019 — Nov 2020 [monthly]

Terminated PHASE2_PHASE3

Status: Unknown Status → Terminated
Jun 2019 — Dec 2019 [monthly]

Unknown Status PHASE2_PHASE3

Status: Recruiting → Unknown Status
Jun 2018 — Jun 2019 [monthly]

Recruiting PHASE2_PHASE3
Jul 2017 — Jun 2018 [monthly]

Recruiting PHASE2_PHASE3
Feb 2017 — Jul 2017 [monthly]

Recruiting PHASE2_PHASE3
Jan 2017 — Feb 2017 [monthly]

Recruiting PHASE2_PHASE3

First recorded

Jan 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute of General Medical Sciences (NIGMS)
National Institutes of Health (NIH)
The University of Texas Medical Branch, Galveston
U.S. Department of Education

Data source: The University of Texas Medical Branch, Galveston

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Galveston, United States